Xtant Medical (XTNT)
(Delayed Data from AMEX)
$0.95 USD
+0.05 (5.38%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $0.92 -0.03 (-3.16%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
XTNT 0.95 +0.05(5.38%)
Will XTNT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for XTNT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for XTNT
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)
Xtant Medical’s Earnings at Risk: The Unhedged Perils of Currency Fluctuations
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023
Xtant Medical files for $150M mixed shelf offering
Xtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript